questionText: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 27 October 2025 to Question 77609 on Medical Treatments: Cost Effectiveness, if he will instruct NICE to review the adequacy of the Quality-Adjusted Life Year threshold for innovative medicines.
answerText: The pharmaceutical sector and the innovative medicines it produces are critical to our national interest, helping people access life changing treatments, reducing pressure on the health service over the longer-term, and ensuring we have a National Health ...
heading: Medical Treatments: Cost Effectiveness